This study reports on variations at the mitochondrial DNA (mtDNA) hypervariable region 1 (HVR-1) and at seven Y-chromosome microsatellites in an African-American population sample from Chicago, IL, USA. Our results support the hypothesis that the population studied had undergone a European malebiased gene flow. We show that comparisons of intraand inter-population diversity parameters between African-Americans, Europeans and Africans may help detect sex-biased gene flow, providing a complement to quantitative methods to estimate genetic admixture.
INTRODUCTION
The European contribution to the gene pool of African populations deported to the United States of America in the course of the Atlantic slave trade may be regarded to as a paradigmatic case of gene flow in human populations [1, 2] . Coherently, studies of genetic structure of present day African-Americans have attracted a particular interest in molecular anthropology [3] . The earliest investigations based on protein loci estimated a 4.0-30.0% proportion of European genes in African-Americans, pointing to a higher admixture in northern rather than in southern US regions [6] . More recent studies, based on autosomal DNA poly-morphisms, highlighted the level of admixture for northern US populations to be lower than previously thought, and the lack of a close relationship between latitude and extent of European admixtures [7] . The introduction of uni linear DNA polymorphisms of mitochondrial DNA (mtDNA) and non recombining portions of Y-chromosome, has made it possible to separately study the male and female European contribution to the African-American gene pool [7] [8] [9] . Finally, further refinements have been obtained with the introduction of genome wide approaches [10, 11] .
In a previous study, we used 10 autosomal microsatel-lites and an Alu polymorphism to explore the genetic structure of an African-American population from Chicago, IL, USA [12] . In this study, we analyzed the variation at the mtDNA hypervariable region 1 (HVR-1) and at seven microsatellites of the Y-chromosome in the same population sample. Using a broad population dataset, we showed that comparisons of intra-and inter-population diversity parameters between African-Americans, Europeans and Africans may help detect sex-biased gene flow, providing a complement to quantitative methods to estimate genetic admixtures.
MATERIALS AND METHODS
A total of 50 individuals (23 males and 27 females) was available for this study. Appropriate informed consent was obtained from all individuals participating in the study. Sequencing of the HVR-1 of mtDNA from nucleotide (nt) positions 16024 to 16383, and determination of size variations at loci DYS19, DYS389I, DYS389II, DYS390, DYS391, DYS392 and DYS393, was performed as previously described [13, 14] . The amplified products were analyzed in polyacrylamide denaturing gels using a semi-automated DNA sequencer (A.L.F. express; Pharma-cia Biotech, Uppsala, Sweden). Allelic and internal standards were used for microsatellite typing.
The dataset for comparison was built selecting data from the mtDNA and Y-chromosomal literature for European and 10 African populations. We have preferentially used widely dispersed populations which could have contributed to the gene pool of present day African-Americans and/or have not undergone drift events in their evolutionary history (Supplementary Table 1 ). Moreover, data for four African-American samples were considered [15] [16] [17] .
Parameters of intra-population diversity [haplotype diversity (HD) and mean number of pairwise differences (MNPD)] and genetic distances between populations were calculated using the Arlequin software ver. 3.5 [18] . Given the relatively high differentiation expected between African and European haplotypes, molecular methods were used in addition to the haplotypic ones to detect further signatures of admixture.
RESULTS AND DISCUSSION
Mitochondrial DNA and Y-Chromosomal Variation. DNA sequences of the HVR-1 were determined in 50 unrelated individuals (Table 1) . We found nucleotide differences at 63 out of 360 positions with respect to the 'consensus' sequence [19] , five of which were transversions [16114 (A>C); 16183 (A>C); 16188 (C>G); 16258 (T>A)]. In total, we were able to define 40 different lineages, with frequencies ranging from 0.002 to 0.008. We obtained a HD value of 0.987 ± 0.008 and a MNPD value of 7.673 ± 3.637.
Y-Chromosomal haplotypes, built using seven microsatellite loci, were determined in 23 individuals (Table 2) . Nineteen different haplotypes were observed, with frequencies ranging from 0.042 to 0.125. We obtained a HD value of 0.996 ± 0.014 and a MNPD value of 4.383 ±2.246.
Intra-and Inter-population Diversity in African-American and African Populations. Since the seminal work by [20] , the approach based on the simultaneous use of mtDNA and Y-chromosomal polymorphisms has been used in numerous studies of human genetic diversity [21] . This approach may also turn out to be useful in the case of AfricanAmerican populations. In fact, the availability of uni linear DNA polymorphisms offers the opportunity to detect possible signatures of a sex-biased gene flow from Europeans to African-Americans. Intriguingly, whereas a male-biased gene flow was expected on the basis of historical knowledge, demographic data indicate that since 1960, most of the mixed marriages involved African-American males to females of European origin [22] .
In a study carried out among African-American students at the Texas University at Austin, Austin, TX, USA, Hsieh and Sutton [23] compared admixture estimates based on mtDNA and protein loci, concluding that there is no evidence of a European male-biased gene flow. On the other hand, the latter case was supported by more recent studies carried out in a number of African-American populations from different areas and based on population specific mtDNA and Y-chromosome alleles [7] [8] [9] [10] .
Estimates of sex-specific admixture suffer from two different orders of limitations. Obtaining reliable African parental populations is difficult for three main reasons. First, present day African-Americans originate from populations scattered in a wide area from the central and western parts of the continent. Second, it is tricky to identify the populations in continuity with those from which slaves were taken to the US, as their demography was reshaped by slave capture and forced migrations [24] . Third, there is also substantial variation among sub-Saharan groups for mtDNA and Y-chromosome polymorphisms [25, 26] , so that results may vary substantially depending on the populations chosen as the parental ones. A further source of confusion may be created by geneticists and molecular anthropologists when they use inaccurate ethnolinguistic labels and/or assume particular populations as representative of wider groups [27] .
The second considerable problem is in the large statistical uncertainty of admixture estimates based on mtDNA and Y-chromosome polymorphisms. Given their intrinsic nature of single loci in evolutionary terms, both the uni linearly transmitted ge- A possible approach is represented by the search for possible effects of gene flow on intra-and interpopulation genetic variation. Since the two genetic systems cannot be directly compared due to substantial difference in types and rate of mutations and demographic dynamics, we have compiled a paired mtDNA and Y-chromosomal population database including both European and African populations [25, 28] . This makes it possible to compare the extent of mtDNA and Y-chromosome variation within a given population, by contrasting it with data from other populations included in the database.
An incoming European male-biased gene flow predicts a greater ratio of Y-chromosome to mtDNA diversity for African-Americans than for African populations. This expectation is met by our AfricanAmerican sample. In fact, their mtDNA HD is equal or lower than in five African populations, whereas their Y-chromosomal value is higher (Table 3 ). The greater diversity of African-Americans is even more evident comparing MNPD, a measure which weighs molecular differences. In this case, the diversity between Europeans and Africans may have a greater impact than happens with HD, in which the extent of inter-haplotypic differentiation is not taken into account. In fact, there are eight African populations with a mtDNA MNPD higher than our African-Americans, and only one for the Y-chromosomal polymorphisms. It is noteworthy that the latter case involves the Fulbe, a population which has been shown to have undergone a male-biased gene flow due to African migrations [29] . Although no inference on asymmetric gene flow can be made for other African-American populations, it is remarkable that the ratio between molecular and haplotypic measures of intra-population diversity are the lowest for mtDNA and the highest for Y-chromosome polymorphisms ( Figure 1) .
A male-biased gene flow in African-Americans from Chicago, IL, USA is also supported by the analysis of genetic distances (Table 4) . They show the lowest genetic distance (both molecular and haplotypic from Europeans for Y-chromosomal polymorphisms but not for the mtDNA ones. Furthermore, the ratio of mtDNA to Y-chromosomal genetic distances from Europeans is markedly higher (18.3-38 .3% for molecular and haplotypic distances, respectively) than all African groups. The introgression of Y-chromosomes into other African-American populations is consistent with their comparatively low genetic distance from Europeans.
To sum up, our results coherently support the hypothesis that the African-American sample under study has undergone a European male-biased gene flow. On a more general note, our research showed that comparative analysis of intra-and inter-population variation for Y-chromosome and mtDNA polymorphisms in a broad dataset including African and 
ABSTRACT
Centromere-near gain of copy number can be induced by intra-or inter-chromosomal rearrangements or by the presence of a small supernumerary marker chromosome (sSMC). Interestingly, partial trisomy to hexasomy of euchromatic material may be present in clinically healthy or affected individuals, depending on origin and size of chromosomal material involved. Here we report the known minimal sizes of all centromere-near, i.e., proximal auto-somal regions in humans, which are tolerated; over 100 Mb of coding DNA are comprised in these regions. Additionally, we have summarized the typical symptoms for nine proximal autosomal regions including genes obviously sensitive to copy numbers. Overall, studying the carriers of specific chromosomal imbalances using genomics-based medicine, combined with single cell analysis can provide the genotype-phenotype correlations and can also give hints where copy-numbersensitive genes are located in the human genome.
INTRODUCTION
Autosomal Proximal Chromosome Imbalances. The finding of unbalanced chromosomal abnormalities (UBCA) was recently reviewed and summarized from a total of 200 families. The UBCA usually involve several megabases of DNA. Carriers of such UBCA are ascertained due to adverse reproductive effects or dysmorphic and/or mentally retarded offspring; the carriers themselves have an otherwise normal phenotype. Unbalanced chromosomal abnormalities have been reported for more than 50 euchromatic regions of almost all human autosomes [1, 2] .
Unbalanced chromosomal abnormalities leading to gain of genetic relevant material within the autosomal centromere-near region were not comprehensively followed in the above mentioned studies [1, 2] . Such centro-mere-near, i.e., proximal chromosomal imbalances (C-UBCA), can be induced by small supernumerary marker chromosomes (sSMCs) [3, 4] and also by intrachromo-somal duplications [4] . While the latter are rare events and no reliable data on their frequency is available, sSMCs are present in 0.043% of human beings [5] . With a given population size of 7 × 10 9 individuals, 3 × 10 6 sSMC carriers are presently alive. As ~2/3 of these do not show any symptoms, ~2 × 10 6 do not even know of their condition. Euchromatin is present in ~36.0% of those sSMC cases that do not lead to any clinical symptoms (Table  1 ) [6] . N.B.: sSMC, irrespective of origin and genetic constitution may cause fertility problems, especially in males [7] . Thus, infertility was not considered as an 'abnormal phenotype' in this study.
Even though partial trisomy is the most frequent imbalance induced by sSMC, tetra-or even hexasomy of proximal euchromatin may be present in clinically healthy individuals [6] . Here we present the latest known proximal, centromere-near regions and their minimal molecular borders. The corresponding index cases were previously published and are summarized on the sSMC homepage [6] . This study intends to give a review on the clinical impact of proximal autosomal imbalances. A special focus is hereby laid on gain of copy numbers. For this, the following steps were necessary: i) define the pericentric regions that can be present as additional copy(ies) without causing any clinical phenotype. ii) After the definition of such copy number insensitive regions, in a second step, proximal autosomal regions including genes potentially sensitive to copy numbers can be defined. iii) Such copy number sensitive regions can be correlated with specific, typical symptoms; the latter already being possible for nine centromere-near regions in this study and there will be more in the future.
What Can be Learned From Cases With Chromosome Imbalances? It was nicely summarized back in 1993 [8] that structural autosomal imbalances may lead in 'typical cases' to syndromes with a complex of minor anomalies and/or congenital malformations. The latter 'suggests the importance of gene interaction in determining the phe-notypic picture of autosomal imbalance syndromes' [8] . Duplication-related syndromes are much more frequent than deletion-related ones, and thus, it is common sense that in general, duplications of several Mb in size are better tolerated by the human genome than deletions of the same size. This has also recently been confirmed on the level of micro-duplications and -deletions [9] . Overall, chromosomal imbalances can point towards dosage sensitive genes being responsible for specific syndromes or clinical features. A good example is the dosage sensitive peripheral myelin protein 22 (PMP22) gene in 17p11.2: a duplication of 1.4 Mb including PMP22 leads to the hereditary motor and sensory neuropathy type 1A and the reciprocal deletion to the hereditary neuropathy with liability to pressure palsies. However, also specific mutations in PMP22 itself can cause the identical syndromes [10] .
Moreover, UBCA of several Mb in size have been reported, which surprisingly, do not have any clinical consequences [1, 2] . At the same time, they are not pure copy number variants (CNV) such as those recently found for a cytogenetically visible amplified region in 8q21.2 [11] . In summary, there are genetically relevant regions which can be tolerated if 'amplified' as three or more copies; the reason for that is most likely that they do not comprise dosage sensitive genes. In summary, studying carriers of specific chromosomal imbalances can provide genotype-phenotype-correlations, and also give hints as to where copy-number-(in)sensitive genes are located in our genome.
Where to Find Proximal Chromosome Imbalances in Humans. Centromere-near imbalances may principally appear as deletions or duplications. However, practically no reports of proximal deletions are available in the literature. The only exceptions are offspring of carriers with an sSMC formed by the McClintock mechanism [12] , e.g., as reported for a child Table 1 . Summarized here are 478 autosomal derived sSMC cases, which are characterized in detail for their size and genetic content; all of them can be found on the sSMC homepage [6] . All these cases are not associated with any clinical abnormalities. In 174, i.e., 36.4%, proximal euchromatic material was present. As can be seen, the rates of cases with and without euchromatin vary from chromosome to chromosome. In general, in acrocentric derived sSMC, cases without euchromatin are in the majority, while it is the other way round in most non acrocentric derived sSMC.
Chromosomes
Cases 1  10  6  1  11  2  1  12  6  2  13  1  0  14  6  53  15  35  136  16  11  8  17  2  0  18  9  2  19  5  1  20  6  6  21  8  1  22  16  69  Overall  174  304 having the karyotype 47,XY,del(2) (p12p11.1) due to a maternal cytogenetic condition (47,XX,del(2) (p12p11.1),+r(2)(::p12→p11.1::) [13] . Only eight corresponding cases are available in the literature [6] and all these patients were severely affected. The best suited patients to study proximal duplications would be those with proximal intrachromosomal rearrangements, as direct or inverted duplications or unbalanced insertions, because these cases would be non mosaic [4] . However, such cases are scarce (summarized in Table 2 ). Most of these ~200 cases were only studied cytogenet-ically and no information on the molecular size of their duplicated region is available [6] .
In contrast, the largest and best characterized group where to find proximal duplications are patients with sSMC [3] [4] [5] [6] [7] [14] [15] [16] . Besides their cytogenetic characterization, more and more cases were characterized at the molecular level by array-comparative genomic hybridization (aCGH) studies [4, 17, 18] . However, when analyzing this group of patients one has to consider the following drawbacks: i) sSMC carriers may be mosaic with normal cell lines and/or may have different levels of mosaicism in different tissues; thus, harmful sSMC sizes may be rated as harmless [19] , and ii) also harmless sSMC may be considered to be harmful if they appear together with a uniparental disomy (UPD) [20] , or a mutation in a mono genic disorder gene [21] . Thus, results for regions including or excluding most likely dosage-sensitive genes, i.e., C-UBCA, have to be handled carefully. Nevertheless, sSMC carriers are much more frequent and better characterized on the molecular level than intrachromosomal duplications, and are thus used here as a model system for proximal duplications.
MATERIALS AND METHODS
This study is based on the data summarized on the sSMC-homepage [6] . All raw data is freely available and can be followed down to each individual case. The data used for the present study is summarized in Tables 1 through 4 .
Proximal Chromosomal Imbalances Without Clinical Consequences. The available in detail characterized sSMC cases [6] were studied by various approaches. In the majority of cases, the sSMC were characterized exclusively by molecular cytogenetics and the breakpoints are given as cytobands without molecular assessment of the exact breakpoint. In addition, there are already numerous sSMC cases characterized by well-defined locus-specific probes used in fluorescence in situ hybridization (FISH) and/or by aCGH [6] . In Table 3 , the presently characterized C-UBCA are summarized. Overall, it could be shown that at least 96.8 Mb of the proximal chromosomal regions are tolerated as triplicates or more (Table  3) . While for proximal 6q there is neither molecular nor cytogenetic hint for any dosage independent C-UBCA, in all other proximal autosomal parts at least cytogenetic evidence for C-UBCA in healthy individuals is there.
Except for proximal parts of 1q, 6p, 6q and 13q, there are molecular hints on C-UBCA for every chromosome arm, being at least between 0.07 and 10.23 Mb in size. According to cytogenetics, no less than 16 of the 39 autosomal proximal non dosage sensitive regions (= C-UBCA) are larger than already proven by aCGH, i.e., 2p, 3p, 3q, 6p, 8p, 8q, 9p, 9q, 10p, 10q,  11p, 12p, 19p, 19q , 20p and 22q (Table 3) . Table 2 . The ~200 case reports of proximal intra-autosomal duplications are summarized per autosome and distinguished in clinically normal and abnormal cases [6] .
Chromosomes
Clinically Normal 1  15  32  >50  16  2  16  17  0  5  18  22  3  19  0  0  20  0  4  21  0  3  22  3  3  Overall  68  >134 Table 3 . All 39 proximal autosomal regions containing no copy number-sensitive genes are summarized. According to the sSMChomepage [6] , the positions and sizes of duplications are given in columns 2 and 3. Column 4 summarizes if the C-UBCA may be larger according to non molecular cytogenetic results. Additionally, in the last two columns it is indicated if the C-UBCA is based on mosaic or non mosaic sSMC cases, and if more than three copies were present in the corresponding index cases. (UCSC: University of California Santa Cruz genome browser; http://genome.ucsc.edu). Twenty-four of the 38 informative proximal autosomal regions are based on mosaic sSMC cases. Thus, the data summarized in Table 3 is still to be considered as preliminary in those cases, even though in >99.0% of sSMC cases, mosaicism detected in peripheral blood plays a minor role for the clinical outcome [22] . Mosaicism may play a role for the phenotype if its rates are variant in different tissues of the body [23] . The C-UBCA regions 1p, 3p, 5p, 10p, 10q, 11p, 13q, 14q, 15q, 16p, 16q, 18p, 21q and 22q were reported in non mosaic cases. The remaining regions await such proof.
Clinically
Abnormal 1 1 8 2 0 5 3 0 1 4 0 2 5 0 4 6 0 3 7 0 2 8 0 2 9 4 2 10 1 4 11 3 3 12 0 11 13 0 2 14 0
Chromosomes
Another issue to be reflected is the copy number of a C-UBCA tolerated by the human genome. At least, for 15 C-UBCA low mosaics (maximum 20.0%) of cells having four (or in one case of 20q up to six) copies of the corresponding regions are tolerated. The C-UBCA of chromosomes 13q, 14q and 15q can be present in four copies in normal carriers in 100.0% of the studied cells. For 15q, even six copies are possible (Table 3) .
Autosomal Proximal Imbalances Leading to Clinical Consequences. In case an sSMC or an intrachromo-somal duplication is larger than the critical region for harmless sSMC, as summarized Table 3 , a variety of clinical problems can be the consequence for the sSMC carrier. Besides well-known syndromes such as isochromosome-12p (Pallister-Killian syndrome) [24] , -15q [25] , -18p [26] or -22q (cat-eyesyndrome) [27] , a variety of symptoms can be associated with an sSMC-induced imbalance [3, 6] . In most cases the correlated symptoms are rather non specific. However, first potentially specific symptom combinations for nine corresponding imbalances are summarized in Table 4 . In future, it should be possible for at least some of these proximal autosomal imbalances to define new, possibly even clinically recognizable, syndromes [3] .
CONCLUSIONS
The sSMC are a long time underestimated source for the understanding of proximal chromosomal imbalances in humans. New information on regions of the human genome, possibly inert to copy number changes, can be acquired from this group of patients. Moreover, effects such as heterochromatization [3] or feedback-loops in gene regulation [28] might also be considered for the understanding of the effects of such imbalances. Comprehensive studies of more aberrant cases will also lead to new genotypephenotype correlations and to the possibility of a clinical sub-differentiation of more sSMC cases. All these goals can only be achieved by a sophisticated balance of single cell analysis (such as in mosaic cases) and genomics-based medicine (such as for array-based approaches).
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Symptom -Chromosome
Autism + - - - - - - - - Finger/toe/foot malformations + - - - + - - - - Growth retardation - + - - - + - - - Heart defects - + - - - - - - - Hernia - - - + - - + - - Hypotonia + - - + - - - - + Macrocephaly - - - + - - - - - Overgrowth - - + - + - - - - Seizures - - - - - - - - - Urethral problems - - - - - - - +
ABSTRACT
Cytogenetic heteromorphisms are described as variations at specific chromosomal regions with no impact on phenotype. The purpose of this study was to investigate the effects of these chromosomal polymorphisms involved in reproductive failure in the Romanian population.
One thousand eight hundred and nine infertile patients, who were referred to Life Memorial Hospital, Bucharest, Romania, between January 2008 and April 2011, were investigated in this retrospective study. The frequency of chromosomal polymorphic variations was calculated for these patients. The control group is represented by 1116 fetuses investigated by amniocentesis between January 2009 and April 2011.
In this study 122 (6.74%) infertile patients and 63 fetuses (5.65%) showed chromosomal polymorphic variations. The differences between the two groups was not statistically significant (p <0.242) but there was statistical significance for some specific chromosomal polymor-phisms [inv(9),1qh+, 9qh+, fra (17) ].
Some chromosomal polymorphic variations appear to be associated with reproductive failure. The statistically significantly higher incidence of heterochromatic variations found in infertile individuals emphasizes the need to assess their role in infertility and subfertility.
Keywords: Chromosomal abnormalities; Heterochromatic variations; Infertility; Inversion; Subfertility.
INTRODUCTION
Infertility is a significant marital problem, affecting up to 15.0% of couples of reproductive age [1, 2] . Infertility can be caused by defects in the development of the urogenital system or defects in function of the endocrine system, including the hypothalamicpituitary-gonadal axis, or by defects in gametogenesis, sexual function, fertilization or early embryonic development [3] . Secondary or acquired infertility, such as after tubal diseases, vasectomy or exposure to gonadotoxins may also occur [4] .
Genetic pathology is an increasingly important part of general human pathology as the number of described genetic diseases and their frequency increases. Study of human chromosomes play a key role in diagnosis, prognosis, treatment and monitoring of chromosomal abnormalities. In order to provide genetical counseling for affected families, cytogenetic analysis is the crucial investigation.
Several studies have been published regarding chromosome analysis in couples with reproductive failure who are referred for IVF (in vitro fertilization) or other treatments [5] . The incidence of chromosomal abnormalities in people with infertility appears to be greater than the overall incidence of chromosomal abnormalities in the general population [6] . It is unclear whether chromosomal abnormalities are one of the main causes of infertility in the human population. Many researchers believe that there is an association between genetic abnormalities and infertility in both men and women [7, 8] . Approximately 40.0% of infertility cases are due to male pathology, 40.0% to female pathology, and the remaining 20.0% is a combination of the two [8] . About 5.0% of infertile men have chromosomal abnormalities, most of which involve sex chromosomes.
Chromosomal abnormalities are a major cause of male and female infertility and can be defined as an alteration of function and structure of chromosomes [9] . Cytogenetic abnormalities, both acquired and inherited, are one of the most common genetic causes of miscarriages early in pregnancies [10] . Most chromosomal abnormalities may cause a genetic imbalance that causes various phenotypic abnormalities (delayed growth and development, multiple congenital anomalies, disorders of sexuality and reproduction, etc.) due to partial trisomy or monosomy of the regions involved. Cytogenetic studies have been reported to determine the contribution of chromosomal abnormalities in patients with reproductive failure [11] .
The purpose of the present study was to investigate the effects of chromosomal polymorphic variations involved in reproductive failure. Polymorphism variations mainly refer to the variants in the chromosomal heterochromatin region. To be classified as variants, chromosomal poly-morphisms needed to be at least twice the size of the corresponding region on the second homologous chromosome [2] . Polymorphic variants on non acrocentric chromosomes usually occur in the paracentric heterochromatin on the long arms of chromosomes 1, 9 and 16, the shortarm regions of the D and G group chromosomes, and the distal heterochromatin of the Y chromosome. Increased lengths of the heterochromatic regions on the long arms of these chromosomes are designated as 1qh+, 9qh+, 16qh+ and Yqh+. The heterochromatin can be reduced in these chromosomes, such as in the case of 1qh−, 9qh− and 16qh−. Increased lengths of the short-arm satellites of the acrocentric D and G group chromosomes (13, 14, 15, 21 and 22) are designated as 14ps+ and 13ps+, while increased lengths of the short arms themselves are designated as p+ (e.g., 15p+) [12] . Because the heterochromatic region consists of highly repeated sequences of satellite DNA that does not encode proteins, the chromosomal polymorphism variations are considered normal karyotypic variations [13] . However, many recent studies indicate that chromosomal polymorphisms may cause certain clinical effects, such as infertility and spontaneous miscarriage [12, 14, 15] .
MATERIALS AND METHODS
During the period from January 2008 to April 2011, 1809 infertile patients (969 men and 840 women) were referred to the Department of Reproductive Medicine, Life Memorial Hospital, Bucharest, Romania. Informed consent was obtained from the patients and donors prior to collection of heparinized blood samples. These patients were investigated for the frequency of chromosomal polymorphic variations. All the patients were evaluated by a skilled medical specialist and tested for antiphospholipid antibodies and relevant hormones. Ultrasonography was performed to rule out other causes of infertility. All cases were Caucasians.
The control group, considered to be a sample of the fertile population, consisted of 1116 fetuses (originating from spontaneous pregnancies). This group was investigated by amniocentesis in the period between January 2009 and April 2011. None of the pregnancies was obtained by an assisted reproductive technique (ART) and the reasons for referral were standard indications for amniocentesis such as abnormal serum screening levels or advanced maternal age.
Amniotic fluid samples were cultured in Amniomax complete medium (Gibco, Grand Island, NY, USA) and peripheral blood samples in PBmax and Chromosome B medium (Gibco); G-banded chromosomes were analyzed after harvesting [16] . At least 15 metaphases were analyzed for each case and 10 metaphases were karyotyped using light microscopy. The banding resolution was 400-550 bands per haploid set (BPHS). The results of the two groups were then compared.
Heteromorphism variations were reported according to the recommendations of the International System for Chromosome Nomenclature 2009 [17, 18] .
Statistical Analyses.
The results for the two groups were compared using the two-tailed Fisher's exact test and calculated on line at the GraphPad Software website (http: //www.graphpad.com/quickcalcs/ contingency1.cfm8).
RESULTS
Cytogenetic analysis revealed a number of numerical and structural abnormalities, but in this study only chromosomal polymorphisms involved in infertility are reported (Table 1) . Chromosomal polymorphism were found in 122/1809 (6.74%) infertile patients in the study group and 63/1116 (5.65%) fetuses in the control group; this was not statistically significant (p = 0.24) (Figure1). The difference between the patients and controls for some specific chromosomal polymorphisms is statistically significant [e.g., inv(9), 1qh+, 9qh+, fra (17)]. This shows that there was a noteworthy relation at risk of infertility and polymorphic variants. The frequencies, according to our study, of the chromosomal polymorphisms for patients and controls are shown in Table 2 . The most common variant observed in infertile couples was inv(9) (2.27%). Other chromosomal variants with a high incidence were 1qh+ (1.22%) and 9qh+ (1.11%).
The least common polymorphic variations in infertile couples were usually observed in the para-centric heterochromatin on the long arms of chromosomes 16, 16qh+ (0.28%), the short-arm of the D and G groups of chromosomes 15ps+ (0.22), 21ps+ (0.33), 22ps+ (0.44%), and the distal heterochromatin of the 46,XY,t(3;9)(q28;q32) 46,XX,t(3;13)(p21;p11.2) 46,XX,t(4;13)(p11;q11) 46,XX,t(9;22)(q34;q11) 46,XX,t(10;19)(q22;q13) 45,XY,t(13;14)(q10;q10) 45,XX,t(14;15)(q10;q10) Figure 1 . Comparison of the frequency of heterochromatic variations in the two studied groups. The distribution of the chromosomal polymorphisms in the two study groups (fetuses and infertile patients) is presented in this image. Y chromosome, Yqh+ (0.16%). The frequency of heteromorphisms in females was 2.76% and 3.98% in males. Twenty males who had heteromorphisms were oligozoospermic or azoosper-mic. The seven women with chromosome heteromor-phisms had normospermic partners. As for the 1116 amniocentesis samples studied, we detected female karyotypes in 533 and male karyotypes in 583 fetuses. We observed polymorphisms in 63 fetuses (5.65%), 30 (1.65%) female and 33 (1.87%) male fetuses. The most frequent types of heteromorphisms in the control group were inv(9) at 3.76%, followed by 1qh+, 9qh+ and 16qh+ variants (0.36, 0.18 and 0.36%, respectively), followed by D and G group variants.
DISCUSSION
Reproductive disorders are closely associated with chromosomal polymorphisms that were considered normal for a long period of time [19] . In recent years, more and more studies have shown an increased incidence of chromosomal polymorphism variation in infertile couples [20, 21] . Some studies have demonstrated that 2.0-14.0% of infertile men have constitutional chromosomal abnormalities [20, 21] . Chromosomal polymorphism between the two sexes in our study group showed some differences: 72 out of 969 men (7.43%) and 50 out of 840 women (5.95%). In both male and female groups, the inversion of chromosome 9 was more frequent. The most common types of chromosomal polymorphism in human infertility include inversion of chromosome 9. The frequency of inversions in the studied group was compared with rates in the population and estimated at 1.0-2.0% [22, 23] . Involvement of chromosome 9 polymorphisms in reproductive failure has been reported previously [24] . There are multiple chromosome 9 heteromorphisms that cannot be detected by GTG-banding or C-banding [25] .
In our study, inversion of chromosome 9 was found in 1.32% men and 0.95% women compared with literature data; 1.52% in men [26] and 0.66% in women [22] . Despite being categorized as a minor chromosomal rearrangement that does not correlate with abnormal phenotypes, many reports in the literature raised conflicting views regarding the association with sterility and subfertility [27, 28] .
In our study, morphological variations of constitutive heterochromatin were frequently detected during cyto-genetic analysis. Most often, chromosomes vary in size and position of heterochromatin in the 1qh, 9qh, and 16qh regions. Although inherited variants have been reported not to be associated with any risk for phenotypic abnormalities, chromosomal heteromorphisms have been found to have a higher frequency relative to the normal population and have been regarded as abnormalities in some studies [11, 17, 20, 21] . Recent studies suggest that classical euchromatic variants of 9qh+/12qh+ and heteromorphism on chromosome 6q may be responsible for recurrent abortions [29, 30] . However, in this study we found a statistical association between some chromosomal polymorphisms, namely, inv(9), 1qh+, 9qh+, fra (17) and infertility. In our study, the frequency of 1qh+ and 9qh+ was statistically signifi- cantly increased in women with primary infertility and in men with azoospermia which was confirmed by other studies [31, 32] . Earlier studies had not investigated polymorphism and chromosomal aberrations as a determining factor in infertility in Romania, therefore, this study could important in this regard.
CONCLUSIONS
Chromosomal abnormalities and even heteromorphisms are significant etiological factors leading to fertility problems. The statistically significantly higher incidence of heterochromatic variations found in infertile individuals in this study emphasizes the need to evaluate their role in infertility and subfertility.
The overall high prevalence of chromosomal polymor-phisms in infertile couples, compared to the normal population, needs to be confirmed with further investigations and larger study populations to delineate the role of "harmless" chromosomal aberrations in the etiology of infertility.
INTRODUCTION
Mental retardation (MR) is characterized by destruction in intellectual abilities, and by an inability to adapt to the environment and the social situation. Mental retardation is found in individuals either as an isolated finding, or as part of an underlying disorder [1] . The worldwide prevalence of MR is about 2.3% [2] . Despite large studies being conducted to discover the etiology of MR, in less than 50% of MR cases is the cause identified and the genetic defect known to be responsible for 17-47% of MR cases [3] .
It is known that numerical and structural chromosomal anomalies are one of the most common causes of MR seen in these patients [4] [5] [6] [7] [8] [9] [10] [11] [12] . Identification of the causes of MR in a patient is of great importance because of the consequences it has for the prognosis, risk of occurrence in other family members, and prevention. Mental retardation is the reason for a substantial portion of referrals of patients and families to the genetic counseling unit. Here we summarize the result of a cytogenetic study performed on 865 mentally retarded Iranian patients consecutively referred to the Cytogenetics Department of the Iran Blood Transfusion Organisation (IBTO) Research Centre, Tehran, Iran.
MATERIALS AND METHODS
Blood samples were collected from 865 idiopathic MR patients who were refereed to IBTO for cytogenetic study. There were 287 females and 578 males. The median age of the patients was 9.5 years. The patients enrolled in this study had unexplained MR. In addition, some of them showed stigmata of dysmorphology, malformations, growth retardation, family history of MR, developmental delay, miscarriages, infertility/subinfertility suggestive of a familial chromosomal translocation/inversion. Chromosomal analysis was performed on phytohemagglutinin (PHA)-stimulated peripheral lymphocyte cultures of the patients using standard cytogenetic methods [13, 14] . A cytogenetic test for fragile X was performed upon request.
Briefly, peripheral blood lymphocytes were cultured in 5 mL RPMI 1640 (Gibco®; Invitrogen, Paisley, Scotland, UK), supplemented with 20% (v/v) fetal bovine serum (GIBCO®; Invitrogen) and 10 µL/mL phytohemagglutinin (PHA) (GIBCO®; Invitrogen) at 37°C. After 72 hours of incubation, 40 µL colcemid (10 µg/mL) (GIBCO®; Invitrogen) was added to the cells. The cells were incubated at 37°C for about 10 mins. The suspension was centrifuged, and the pellet was resuspended in 5-10 mL KCL (0.075 M) for about 20 mins. at 37°C. After centrifugation, the cells resuspended in fixative (3v methanol:1v acetic acid) (Merk, Frankfurt, Germany). The fixative was changed at least three times. Using a Pasteur pipette, a drop was dropped onto the slide. The chromosomes were viewed under phase contrast to assess quality of the metaphases and nuclei. The chromosomes were treated with trypsin, then stained with Giemsa (GTG-banded) after aging.
Twenty to 30 metaphases were analyzed per individual and in cases of suspected mosaicism, the numbers of metaphases were increased to a total of 100 for analysis. A resolution of 450-band stage was considered as a minimum; for a more detailed structural analysis, 550-700-band stage was preferred. The routine analysis was based on GTG-banded staining. For patients with structural chromosome abnormalities or marker chromosomes, a chromosome study of the parents was recommended and performed if the parents were alive and available (some of the patients lived in orphanages) or cooperated.
RESULTS
In our study of 865 screened subjects (287 females, 578 males), anomalies were identified in 205 of the patients (23.6%). The majority were Down's syndrome cases (n = 138, 15.9% of all the screened MR cases, and 67.3% of the cases with chromosome abnormalities). In 33 males, a positive fragile X anomaly was found (3.8% of all the screened MR cases, and 16% of the cases with chromosome abnormalities).
The remainder (n = 34, 3.9% of all the screened MR cases, and 16.5% of the cases with chromosome abnormalities) had other chromosomal abnormalities (Table 1) , mainly structural chromosome aberrations (n = 23). The chromosomal anomalies in these patients were mostly of de novo origin except in six cases (patients #12, #13, #16, #17, #18 and #19).
In five cases parental chromosome study could not be performed (patients #9, #10, #11, #14 and #21).
Marker chromosomes with an unknown origin found in three de novo cases. Sex chromosome aneuploidy was detected in six patients. Twelve cases had inversion 9q which is believed to be a normal variant.
DISCUSSION
There is great variation in the frequency of the reported chromosomal abnormalities found in MR patients. A cytogenetic study of 419 MR school children in southern Taiwan, by Shiue et al [2] , found chromosomal abnormalities in 22.43% of the cases, with trisomy 21 occurring in 77 cases (18.38%). Sex chromosome aneuploidies were found in three cases (0.72%). Structural abnormalities of autosomes were found in 13 cases (3.10%) (2) . Another study of 341 MR children in Taiwan found chromosomal abnormalities in 89 cases (20.3%) including 63 of trisomy 21 (10.7%) and 13 of fragile X (3.8%) [4] .
Coco and Penchaszadeh [5] reported on a cytogenetic study in 200 MR children in Argentina. They found chromosomal abnormalities in 42 (21%) with 26 cases having structural chromosome defects [5] .
Two studies were performed in The Netherlands. One study done in Amsterdam (in the south of The Netherlands) indicated that a chromosomal base in 22.1% of the patients was responsible for their MR. Of these, 14.3% were Down's syndrome patients, and 6.1% had other chromosomal abnormalities [6] . Another study done in Amsterdam indicated that 20 patients had chromosomal anomalies (7.5%) in 266 karyotyped MR children. Interestingly, these were mainly structural chromosome aberrations [7] .
A study performed in Poland showed that the incidence of abnormal karyotypes in MR patients was 10.1% [8] . However, the percentage of chromosome aberrations found in patients with non specific mental retardation was 2.2% [8] . A study done by Butler and Singh [9] in America showed that 39 out of 201 (6.6%) institutionalized MR patients had abnormal chromosome with Down's syndrome noted in 31 of the patients.
While the overall frequency of chromosomal abnormalities in these reports was similar, there are reports of either low or high percentages of chromosomal aberrations in other studies. For example, Celep et al. [10] reported the percentages of chromosomal abnormalities in 457 Turkish MR Patients to be only 4.81%. Chromosomal abnormalities and polymorphisms were detected in 65 (14.21%) (structural and numerical chromosomal abnormalities in 22 patients and polymorphisms in 43) of 457 MR and/ or multiple congenital anomaly (MCA) patients. On the other hand, a study done in Slovakia revealed a very high percentage of chromosome abnormalities in MR patients. Of 324 MR patients, 104 (53.0%) had chromosomal aberrations [11] .
The differences between the incidences of chromosomal abnormalities in the literature could be caused by the criteria for patient selection, and the techniques applied [cytogenetics only or in combination with molecular cytogenetics such as fluorescent in situ hybridization (FISH) and comparative genomic hybridization (CGH)]. In our study of 865 screened subjects, chromosomal anomalies were identified in 205 of the patients (23.6%). The majority were Down's syndrome cases (n = 138, 15.9%). Interestingly, we found three cases with marker chromosomes (0.34%). Liehr and Weise [15] found that the incidence of marker chromosomes is about 0.288% in MR patients.
In general, van Karnebeek et al. [3] showed that the mean yield of chromosome aberrations in classical cytogenetics is about 9.5% (variation: 5.4% in school populations to 13.3% in institute populations; 4.1% in borderline-mild MR to 13.3% in moderateprofound MR; more frequent structural anomalies in females). They also indicated that for fragile X anomalies, yields were 5.4% (cytogenetic studies) and 2.0% (molecular studies) [3] .
The incidence of fragile X positive cases in our study is slightly higher than some other reports although we only employed cytogenetic tests for fragile X. For example, Butler and Singh [9] reported 2.0% fragile X positive in his cases, while in our study it was 3.8%. Nevertheless, our results indicate that the diagnostic contribution of the fragile X screening could be considered equally important as conventional chromosome banding techniques for the detection of structural chromosome abnormalities.
Some of the chromosome aberrations were detected in more than one case. For example: in two cases, chromosome 2 was involved with a very close breakpoint of q22 and q23 (Table 1 ; patients #1 and #14); in two cases, chromosome 4 with breakpoints p16 and p15.3 (Table 1 ; patients #5 and #15); and in
